Does advice from pharmacy staff vary according to the nonprescription medicine requested?

Annals of Pharmacotherapy

Volumn 43, Issue 11, 2009, Pages 1877-1886

  Kelly, Fiona S ^a   Williams, Kylie A ^b   Benrimoj, Shalom I ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Behavior; Nonprescription medicine; OTC (over the counter) medication; Pharmacy; Pseudo patient; Self care; Simulated patient; Support staff

Indexed keywords

CODEINE; DOXYLAMINE; IBUPROFEN; NON PRESCRIPTION DRUG; PARACETAMOL;

ARTICLE; CONSUMER; CONTROLLED STUDY; HEALTH CARE PRACTICE; HEALTH CARE SYSTEM; HUMAN; PHARMACIST; PHARMACIST ATTITUDE; PHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYMPTOM;

AUSTRALIA; COMMUNITY PHARMACY SERVICES; HUMANS; NONPRESCRIPTION DRUGS; PATIENT EDUCATION AS TOPIC; PHARMACISTS; PROFESSIONAL ROLE;

EID: 70449711336     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L121     Document Type: Article

References (42)

1. The role of self-care in the treatment of illness: a profile of the Canadian self-care health product user. Ottawa: NDMAC, 2004.
2. Chui WK, Li SC. Advice-giving on self-medication: perspectives of community pharmacists and consumers in Singapore. J Clin Pharm Ther 2005;30:225-231 DOI 10.1111/j.1365-2710.2005.00637.x
3. Guiding principles in self-medication. London: World Self-Medication Industry, April 1999.
4. Joint statement by the International Pharmaceutical Federation and the World Self-Medication Industry - responsible self-medication. The Hague, 1999:3.
5. National Drugs and Poisons Schedule Committee, Department of Health and Ageing. Standard for the uniform scheduling of drugs and poisons. Canberra: Therapeutic Goods Administration, 2008:417.
6. Achanta AS, Temkin CW, Rhodes CT. Attitudes and opinions towards regulatory aspects of non-prescription medicines. Clin Res Reg Aff 2003; 20:1-14. DOI 10.1081/CRP-120018736
7. Hibbert D, Bissell P, Ward P. Consumerism and professional work in the community pharmacy. Sociol Health Illn 2002;24:46-65.
8. Krska J, John DN, Hansford D, Kennedy EJ. Drug utilization evaluation of non-prescription H2-receptor antagonists and alginate-containing preparations for dyspepsia. J Clin Pharmacol 2000;49:363-368 DOI 10.1046/j.1365-2125.2000. 00160.x
9. Emmerton L, Shaw J. Meditrends: current market purchasing trends for non-prescription medicines. N Z Pharm 2000;20:34-37
10. Taylor J. Reasons consumers do not ask for advice on non-prescription medicines in pharmacies. Int J Pharm Pract 1994;2:209-214
11. Stromme HK, Haugli A. Communication and interaction between customers and pharmacy personnel in two Norwegian pharmacies - an observational study. Int J Pharm Pract 1996;4:209-213 (Pubitemid 27087130)
12. Banks J, Shaw A, Weiss MC. Walking a line between health care and sales: the role of the medicines counter assistants. Pharm J 2005;274:586-589 (Pubitemid 40790044)
13. Ferris DG, Dekle C, June MSL. Women's use of over-the-counter antifungal medications for gynecologic symptoms. Fam Pract 1996;42:595-601.
14. Williams K. Pharmacoepidemiology of non-prescription drugs. Doctorate dissertation. Sydney: University of Sydney, 1998.
15. Galbally R. National competition review of drugs, poisons and controlled substances legislation: Part B. Final report. Canberra: Australian and International Health Institute, December 2000.
16. Center for Drug Evaluation and Research/Office of the Center Director/ Office of Drug Safety. Detailed view: safety labeling changes approved by FDA center for drug evaluation and research - November 2008. Washington: Food and Drug Administration, 2008. www.fda.gov/ medwatch/safety/2008/nov08. htm#Phenylephrine (accessed 2009 Feb 24).
17. Smith FJ, Salkind MR. Factors influencing the extent of the pharmacist's advisory role in greater London. Pharm J 1990;244:R4-6.
18. Center for Drug Evaluation and Research/Office of the Center Director/ Safety Policy and Communication Staff. MEDWATCH - the FDA safety information and adverse event reporting program. Washington: Food and Drug Administration, 2009. www.fda.gov/Safety/MedWatch/ default.htm (accessed 2009 Feb 24).
19. de Almeida Neto AC, Benrimoj SI, Kavanagh DJ, Boakes RA. A novel educational training program for community pharmacists. Am J Pharm Educ 2000;64:302-307
20. Crampton M, Benrimoj SI, Gilbert A, Quintrell N. Standards of practice for the provision of pharmacist only and pharmacy medicines in community pharmacy: final report. Sydney: University of Sydney, University of South Australia, 1998.
21. Benrimoj SI, Gilbert AL. A program to develop and test a mechanism to raise national standards of practice for the provision of pharmacist only and pharmacy medicines in Australian community pharmacy. Final report. Sydney: University of Sydney, University of South Australia, April 2002.
22. Bissell P, Ward PR, Noyce PR. Variation within community pharmacy. Part 1. Responding to requests for over-the-counter medicines. J Soc Admin Pharm 1997;14:1-15. (Pubitemid 27334459)
23. Norris PT. Purchasing restricted medicines in New Zealand pharmacies: results from a "mystery shopper" study. Pharm World Sci 2002;24:149-153 DOI 10.1023/A:1019506120713
24. Bissell P, Ward PR, Noyce PR. Variation within community pharmacy. Part 2. Responding to the presentation of symptoms. J Soc Admin Pharm 1997;14:105-115 (Pubitemid 27317236)
25. Emmerton L, Shaw J. The influence of pharmacy staff in non-prescription medicine sales. Int J Pharm Pract 2002;10:101-106 (Pubitemid 34733345)
26. Benrimoj SI, Raffaele C, Werner JB, Costa F, Roberts AS. Monitoring quality standards in the provision of non-prescription medicines from Australian community pharmacies: results of a national program. Q Saf Health Care 2007;16:354-358 DOI 10.1136/qshc.2006.019463
27. Anderson C, Alexander A. Response to dysmenorrhoea: an assessment of pharmacists' knowledge and its application in practice. Int J Pharm Pract 1993;2:180-183
28. Provision of orlistat as a pharmacist only medicine. Protocol. Canberra: Pharmaceutical Society of Australia, 2004:2.
29. Watson MC, Skelton JR, Bond CM, et al. Simulated patients in the community pharmacy setting. Pharm World Sci 2004;26:32-37 DOI 10.1023/B:PHAR.0000013467.61875.ce
30. Kelly FS. Provision of a non-prescription professional service: the role of the pharmacy assistant. Doctorate dissertation. Sydney: University of Sydney, 2005.
31. Norris P. Which sorts of pharmacies provide more patient counselling? J Health Serv Res Policy 2002;7:S1:23-S1:8. DOI 10.1258/135581902320176430
32. Freemantle N. Implementation strategies. Fam Pract 2000;17:S7-10. DOI 10.1093/fampra/17.suppl-1.S7
33. Berbatis C, Sunderland B, Mills CR, Bulsara M. National pharmacy database project. Final report. Perth: Curtin University, 2003.
34. Benrimoj SI, Gilbert AL, de Almeida Neto AC, Kelly F. National implementation of standards of practice for non-prescription medicines in Australia. Pharm World Sci 2009;31:230-237 DOI 10.1007/s11096-008-9266-8
35. Benrimoj SI, Gilbert A, Quintrell N, de Almeida Neto AC. Non-prescription medicines: a process for standards development and testing in community pharmacy. Pharm World Sci 2007;29:386-394 DOI 10.1007/s11096-007-9086-2 (Pubitemid 47196661)
36. Standards for the provision of pharmacist only and pharmacy medicines in community pharmacy. 3rd ed. Canberra, ACT Australia: Pharmaceutical Society of Australia, 2006:61.
37. Berger K, Eickhoff C, Schultz M. Counselling quality in community pharmacies: implementation of the pseudo customer methodology in Germany. J Clin Pharm Ther 2005;30:45-57. DOI 10.1111/j.1365-2710.2004.00611.x (Pubitemid 41602091)
38. Luck J, Peabody JW. Using standardised patients to measure physicians' practice: validation study using audio recordings. BMJ 2002;325:679-684 DOI 10.1136/bmj.325.7366.679
39. Ward PR, Bissell P, Noyce PR. Criteria for assessing the appropriateness of counseling in community pharmacies. Ann Pharmacother 2000;34: 170-175 DOI 10.1345/aph.19135 (Pubitemid 30082974)
40. Watson MC, Bond CM, Grimshaw JM, Mollison J, Ludbrook A. Educational strategies to promote evidence-based community pharmacy practice: a cluster randomized controlled trial. Fam Pract 2002;19:529-536 DOI 10.1093/fampra/19.5. 529 (Pubitemid 35244241)
41. Kravitz RL, Epstein RM, Feldman MD, et al. Influence of patients' requests for direct-to-consumer advertised antidepressants. JAMA 2005; 293:1995-2002. DOI 10.1001/jama.293.16.1995
42. Ward PR, Bissell P, Noyce PRD. Medicines counter assistants: roles and responsibilities in the sale of deregulated medicines. Int J Pharm Pract 1998;6:207-215 (Pubitemid 29037510)